読む Announcement Concerning a COVID-19 Vaccine Development Partnership with VIDO-InterVac at Dalton Chemical Laboratories, Inc.
読む Consolidated Financial Results for the First Quarter of Fiscal 2020
読む (Update of Previous Disclosure) Seikagaku Announces Completion of Acquisition (Incorporation as a Subsidiary) of Dalton Chemical Laboratories, Inc. and Change in Specified Subsidiaries
読む Ono and Seikagaku Announce the Results from a Phase III Clinical Study in Japan of
ONO-5704/SI-613 in Patients with Knee Osteoarthritis Presented at an Academic Conference
読む Seikagaku announced the financial results for the First Quarter of the Fiscal Year ending March 31, 2021
読む Seikagaku will announce the financial results for the First Quarter of the Fiscal Year ending March 31, 2021 at 15:00 on July 31, 2020.
読む New Message from President & CEO
読む Presentation Material for the Briefing on FY2019
IR E-mail Alert
This link will direct you to a third-party site.（Another window opens.）
Copyright © SEIKAGAKU CORPORATION All rights Reserved.